Literature DB >> 2524600

New retrovirus helper cells with almost no nucleotide sequence homology to retrovirus vectors.

J P Dougherty1, R Wisniewski, S L Yang, B W Rhode, H M Temin.   

Abstract

We prepared retrovirus packaging cell lines containing gag-pol genes from spleen necrosis virus (expressed from a cytomegalovirus promoter and the simian virus 40 (SV40) polyadenylation sequences) and, on a separate vector, either the env gene from spleen necrosis virus (expressed from the Rous sarcoma virus promoter and the SV40 polyadenylation sequences) or the env gene from amphotropic murine leukemia virus (expressed from a cytomegalovirus promoter and the SV40 polyadenylation sequences). The nucleotide sequences in these packaging cell lines have almost no homology to the retrovirus vectors we used. Retrovirus vectors were produced from these new helper cell lines without any genetic interactions between the vectors and sequences in the helper cells and without transfer of the packaging sequences.

Entities:  

Mesh:

Year:  1989        PMID: 2524600      PMCID: PMC250885     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Murine xenotropic type C viruses. III. Phenotypic mixing with avian leukosis and sarcoma viruses.

Authors:  J A Levy
Journal:  Virology       Date:  1977-04       Impact factor: 3.616

Review 2.  Retroviral vectors for introduction of genes into mammalian cells.

Authors:  M A Eglitis; W F Anderson
Journal:  Biotechniques       Date:  1988 Jul-Aug       Impact factor: 1.993

3.  Phenotypic mixing between avian and mammalian RNA tumor viruses: I. Envelope pseudotypes of Rous sarcoma virus.

Authors:  R A Weiss; A L Wong
Journal:  Virology       Date:  1977-02       Impact factor: 3.616

4.  The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection.

Authors:  C M Gorman; G T Merlino; M C Willingham; I Pastan; B H Howard
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

5.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

6.  High-frequency deletion in recovered retrovirus vectors containing exogenous DNA with promoters.

Authors:  M Emerman; H M Temin
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

7.  Correction of the genetic defect in hepatocytes from the Watanabe heritable hyperlipidemic rabbit.

Authors:  J M Wilson; D E Johnston; D M Jefferson; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

8.  A safe packaging line for gene transfer: separating viral genes on two different plasmids.

Authors:  D Markowitz; S Goff; A Bank
Journal:  J Virol       Date:  1988-04       Impact factor: 5.103

9.  Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5' long terminal repeat and the start of the gag gene.

Authors:  S Watanabe; H M Temin
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

10.  Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors.

Authors:  S Watanabe; H M Temin
Journal:  Mol Cell Biol       Date:  1983-12       Impact factor: 4.272

View more
  53 in total

1.  Mutations in the v-Rel transactivation domain indicate altered phosphorylation and identify a subset of NF-kappaB-regulated cell death inhibitors important for v-Rel transforming activity.

Authors:  Béatrice Rayet; Yongjun Fan; Céline Gélinas
Journal:  Mol Cell Biol       Date:  2003-03       Impact factor: 4.272

2.  Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.

Authors:  William Fu; Wei-Shau Hu
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

3.  Packaging cells for avian leukosis virus-based vectors with various host ranges.

Authors:  F L Cosset; C Ronfort; R M Molina; F Flamant; A Drynda; M Benchaibi; S Valsesia; V M Nigon; G Verdier
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion.

Authors:  P Olson; H M Temin; R Dornburg
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

5.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

Authors:  J Kimpton; M Emerman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

6.  Avian reticuloendotheliosis virus strain A and spleen necrosis virus do not infect human cells.

Authors:  R Gautier; A Jiang; V Rousseau; R Dornburg; T Jaffredo
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

7.  Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.

Authors:  T Masuda; V Planelles; P Krogstad; I S Chen
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

8.  E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy.

Authors:  J G Julias; D Hash; V K Pathak
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Incorporation of homologous and heterologous proteins into the envelope of Moloney murine leukemia virus.

Authors:  M Suomalainen; H Garoff
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

10.  Antisense suppression of skeletal muscle myosin light chain-1 biosynthesis impairs myofibrillogenesis in cultured myotubes.

Authors:  R Nawrotzki; D A Fischman; T Mikawa
Journal:  J Muscle Res Cell Motil       Date:  1995-02       Impact factor: 2.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.